Solana (NASDAQ:HSDT – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued to investors on Saturday, Wall Street Zen reports.
A number of other brokerages have also commented on HSDT. Weiss Ratings reissued a “sell (e+)” rating on shares of Solana in a research report on Thursday, October 15th. B. Riley Financial decreased their target price on shares of Solana from $4.00 to $3.00 and set a “buy” rating for the company in a research report on Thursday. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Solana presently has a consensus rating of “Hold” and an average price target of $3.50.
View Our Latest Stock Analysis on Solana
Solana Stock Performance
NASDAQ HSDT opened at $1.73 on Friday. The stock has a market capitalization of $105.07 million, a price-to-earnings ratio of 0.46 and a beta of 1.10. The stock’s 50 day moving average price is $2.35 and its two-hundred day moving average price is $2.05. Solana has a 52 week low of $1.19 and a 52 week high of $4.93.
Solana (NASDAQ:HSDT – Get Free Report) last released its quarterly earnings results on Wednesday, November 11th. The company reported $1.17 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.01) by $1.18. The firm had revenue of $3.36 million during the quarter, compared to the consensus estimate of $2.85 million. Solana had a return on equity of 128.12% and a net margin of 2,040.43%. On average, equities research analysts forecast that Solana will post -1.14 EPS for the current year.
Hedge Funds Weigh In On Solana
An institutional investor recently bought a new position in Solana stock. Saba Capital Management L.P. acquired a new stake in Solana Company (NASDAQ:HSDT – Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 65,210 shares of the company’s stock, valued at approximately $113,000. Saba Capital Management L.P. owned 0.12% of Solana at the end of the most recent reporting period. 18.63% of the stock is owned by hedge funds and other institutional investors.
Solana Company Profile
Solana Company (NASDAQ: HSDT) is a publicly traded company focused on a digital-asset treasury strategy centered on SOL, the native token of the Solana blockchain. It is a corporate holder of Solana-related digital assets, rather than the operator of the Solana network. The company was formerly Helius Medical Technologies, a medical technology business that developed the Portable Neuromodulation Stimulator (PoNS), a device designed to support rehabilitation for people with certain neurological conditions.
See Also
- Five stocks we like better than Solana
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Solana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solana and related companies with MarketBeat.com's FREE daily email newsletter.
